CME Financial Facts
Equity in net losses of unconsolidated subsidiaries: 28.6MTotal Expenses: 316.4M
See Full Income Statement
Accounts payable: 34.5M
Total current liabilities: 31.89B
See Full Balance Sheet
CME Group Inc. (CME) Earnings
|
Expand Research on CME
| Next EPS Date | 7/23/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.9% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/29/26 |
Q126 | N/A | $3.04 | N/A | N/A | $1.73B | N/A | N/A | N/A | ||
| 2/4/26 | Q425 | $2.77 | $2.75 | +$0.02 | $1.65B | $1.64B | N/A | ![]() | ![]() | Details | |
| 10/22/25 | Q325 | $2.68 | $2.64 | +$0.04 | $1.5B | $1.53B | N/A | ![]() | ![]() | Details | |
| 7/23/25 | Q225 | $2.96 | $2.93 | +$0.03 | $1.7B | $1.68B | N/A | ![]() | ![]() | Details | |
| 4/23/25 | Q125 | $2.80 | $2.68 | +$0.12 | $1.64B | $1.59B | N/A | ![]() | ![]() | Details | |
| 2/12/25 | Q424 | $2.52 | $2.48 | +$0.04 | $1.53B | $1.53B | N/A | ![]() | ![]() | Details | |
| 10/23/24 | Q324 | $2.68 | $2.64 | +$0.04 | $1.58B | $1.59B | N/A | ![]() | ![]() | Details | |
| 7/24/24 | Q224 | $2.56 | $2.54 | +$0.02 | $1.53B | $1.53B | N/A | ![]() | ![]() | Details |


